Objective: Evaluation of the effects of iodine fortified-milk on lactating mothers’ and their infants’ iodine nutrition status. Design: Multicenter clinical trial. Setting and conduct: A-Participants including major eligibility criteria- Major inclusion criteria: Lactating mothers and their infants Major exclusion criteria: Thyroid diseases in mothers and their infants, neonate hypothyroidism- Sample size:52 B- Intervention: Iodine-enriched milk C-Intervention time: 3-5, 7, 10,14 days and 1, 2 months after delivery D-Main outcome: Breast milk and urinary iodine concentrations
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201305074794N9
Registration date:2013-05-20, 1392/02/30
Registration timing:prospective
Last update:
Update count:0
Registration date
2013-05-20, 1392/02/30
Registrant information
Name
Fereidoun Azizi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2240 9309
Email address
azizi@endocrine.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice Chancellor for Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
Expected recruitment start date
2013-06-22, 1392/04/01
Expected recruitment end date
2013-12-22, 1392/10/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effects of iodine fortified-milk on lactating mothers’ and their infants’ iodine nutrition status
Public title
Iodine fortified-milk and iodine nutrition in lactating mothers and their infants
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:Lactating mothers; full-term infants(37-42 weeks) with normal birth weight (2500-4200 g); neonates with age 3-5 days.
Exclusion criteria: Having thyroid diseases; taking anti- thyroid medications; using iodine containing supplements; neonate hypothyroidism
Age
From 15 years old to 45 years old
Gender
Female
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
52
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
ٍEthics Committee, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical